A previous study shows that sCD46 is elevated in the serum of patients with active SLE and its levels are correlated with complement activation, which suggests that CD46 can be used as a biomarker for certain autoimmune diseases27, 28. This evidence concerns the gene CD46 and systemic lupus erythematosus.